Showing results (301-310 of 582) with videos related to
Sort By:
Pageof 59
Movement Disorders : Official Journal of the Movement Disorder Society|December 16, 2003
Phenotypic features of Huntington's disease-like 2Ruth H Walker, Joseph Jankovic, Elizabeth O'Hearn, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 13, 2013
The spectrum of movement disorders in children with anti-NMDA receptor encephalitisJosé Fidel Baizabal-Carvallo, Amber Stocco, Eyal Muscal, et al.FEBS Letters|November 30, 2005
Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cellsTianhong Pan, Xinqun Li, Wenjie Xie, et al.World Neurosurgery|October 1, 2013
Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonismAkash J Patel, Aliya I Sarwar, Joseph Jankovic, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 15, 2018
Leg stereotypy syndrome: phenomenology and prevalenceMitesh Lotia, Michele K York, Adriana M Strutt, et al.Expert Review of Neurotherapeutics|June 16, 2022
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson's diseaseAbhishek Lenka, Gianluca Di Maria, Guillaume Lamotte, et al.Clinical Neuropharmacology|December 23, 2004
An open-label pilot study of levetiracetam for essential tremorWilliam G Ondo, J Ernesto Jimenez, Kevin Dat Vuong, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 3, 2013
Analysis of CYP2D6 genotype and response to tetrabenazineRaja Mehanna, Christine Hunter, Anthony Davidson, et al.Parkinsonism & Related Disorders|June 22, 2011
The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonismAinhi D Ha, Caitlin H Brown, Michele K York, et al.Clinical Neuropharmacology|October 3, 2007
Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson diseasePeter A LeWitt, Babak Boroojerdi, Douglas MacMahon, et al.Pageof 59